Cancer Prevention and Control Program

The overall goal of the Cancer Prevention and Control Program of the Wake Forest Baptist Comprehensive Cancer Center is is scientific discovery across the cancer continuum—from primary prevention to survivorship—which translates into clinical, community, and policy strategies to improve cancer outcomes. CPC members reduce the risk of incidence of cancer and recurrence through epidemiological and applied behavioral research to decrease tobacco use and obesity. The Program also enhances survivors’ quality of life by conducting surveillance of post-treatment effects of cancer and cancer care delivery research to improve survivorship outcomes. The CPC Program capitalizes on Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) and institutional resources such as the Office of Cancer Health Equity, the Wake Forest Clinical and Translational Science Institute, and the Maya Angelou Center for Health Equity to support its research. In particular, as a National Cancer Institute Community Oncology Research Program (NCORP), the WFBCCC is well-positioned to support multi-center, rigorous cancer prevention and control research in community-based health care settings. 

The Specific Aims of the CPC Program are to: 

Aim 1. Improve modifiable risk factors that will reduce cancer incidence, morbidity, and mortality, with a strategic focus on tobacco control and obesity. Research in this Aim focuses on the primary prevention of tobacco use and addiction, including reducing the use of cigarettes and other tobacco products among adolescents and young adults; improving cessation by targeting populations at high risk of tobacco-induced morbidity and mortality; and identifying and modifying obesity-related risk factors for cancer, including nutritional opportunities for weight management and chemoprevention.

Aim 2. Enhance survivorship outcomes, with a focus on quality of life, incorporating patient-reported outcomes into survivorship care, and addressing the symptoms and long-term effects of cancer treatment. This Aim incorporates research focused on psychosocial well-being of survivors across the lifespan, integrating patient-reported outcomes into survivorship care planning and post-treatment surveillance, and addressing chemotherapy-induced cardiovascular damage among cancer survivors. As the WFBCCC expands its precision oncology clinical research and services, the CPC Program will prioritize research addressing patient perspectives, decision-making, and outcomes in precision oncology.

Cross-cutting these Aims is our emphasis on reducing health disparities across different socioeconomic, racial, and geographic groups. In all areas of research, we are committed to the unique populations of the region (e.g., African-Americans, Native Americans, Latinos, low-income, rural).

Contact us: 

Kristie L. Foley, PhD, Program Leader

Kathryn Weaver, PhD, Program Co-Leader

Last Updated: 01-29-2016
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.